Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00983359 · ClinicalTrials.gov registry record · NA
Stereotactic Radiation Therapy in Treating Patients With Brain Metastases
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT00983359 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 40 participants.
The verdict
NCT00983359, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
RATIONALE: Stereotactic radiation therapy may be able to send x-rays directly to the tumor and cause less damage to normal tissue. PURPOSE: This phase II trial is study how well stereotactic radiation therapy works in treating patients with brain metastases
Interventions
- RADIATION Radiation Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2007-04 |
| Est. Completion | 2012-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00983359
The ClinicalTrials.gov registry entry for NCT00983359 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Radiation Therapy is the first listed.
NCT00983359 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00983359 about?
NCT00983359 is a clinical study titled "Stereotactic Radiation Therapy in Treating Patients With Brain Metastases". RATIONALE: Stereotactic radiation therapy may be able to send x-rays directly to the tumor and cause less damage to normal tissue. PURPOSE: This phase II trial is study how well stereotactic radiation therapy works in treating patients with brain metastases
What is the current status of trial NCT00983359?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2007-04. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00983359?
The interventions under investigation include: Radiation Therapy (RADIATION).
Who is sponsoring clinical trial NCT00983359?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.